Rayno Life Science Portfolio Gets ASCO Boost With Antibody Drug Conjugates
Antibody Drug Conjugates Make Progress for Cancer Therapy- Immunogen and Seattle Genetics Many of our focus stocks were up today helped by a late day rally that brought the NASDAQ up 0.46% at the close. Major biotechnology ETF's (IBB,XBI) also recovered with some green by the end of the day.The...
MO Gang Taking Profits With Risk OFF
Jobs Number Spooks Traders-Dow Erases Gains for the Year Large cap biotechnology and MO growth stocks are taking a big hit today as hedgies take profits. Many of these stocks are still up YTD but profits are quickly eroding. Stocks to watch in technology, retail and biotechnology are :Intuitive...
Risk Still OFF with Euro Malaise
Look for biotechnology intermediate top as we approach ASCO next week. Market is now driven by hedgies and big funds.IBB ($123.90) double top with YTD high of $126.90 Mid cap biotech index off 1.7%. DX and tools also very weak. S&P unchanged from one year...
Notes from B Riley 13th Annual Investor Conference: CEMI,VRML
There were some excellent small cap companies presenting at the B. Riley Investor Conference in Santa Monica this week. Five tracks covered companies in healthcare, technology and energy, consumer/telecom, software and services and internet and media. Our focus within healthcare is...
Todays’ Sell-Off Finally Hits Resilient Biotech Stocks
Facebook Hype Effect-Sell MO Stocks? Many of the favorite momentum stocks are being hit with profit taking today including large cap biopharmaceutical stocks. With the NASDAQ down 0.8% at 2850, we see a lot of countertrends like gold up $39.70 off recent lows to $1576 accompanied by a big...